Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,447 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer.
Boccardo F, Rubagotti A, Battaglia M, Di Tonno P, Selvaggi FP, Conti G, Comeri G, Bertaccini A, Martorana G, Galassi P, Zattoni F, Macchiarella A, Siragusa A, Muscas G, Durand F, Potenzoni D, Manganelli A, Ferraris V, Montefiore F. Boccardo F, et al. Among authors: conti g. J Clin Oncol. 2005 Feb 1;23(4):808-15. doi: 10.1200/JCO.2005.12.013. J Clin Oncol. 2005. PMID: 15681525 Clinical Trial.
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study.
Boccardo F, Rubagotti A, Barichello M, Battaglia M, Carmignani G, Comeri G, Conti G, Cruciani G, Dammino S, Delliponti U, Ditonno P, Ferraris V, Lilliu S, Montefiore F, Portoghese F, Spano G. Boccardo F, et al. Among authors: conti g. J Clin Oncol. 1999 Jul;17(7):2027-38. doi: 10.1200/JCO.1999.17.7.2027. J Clin Oncol. 1999. PMID: 10561254 Clinical Trial.
Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
Boccardo F, Rubagotti A, Conti G, Potenzoni D, Manganelli A, Del Monaco D. Boccardo F, et al. Among authors: conti g. Cancer Chemother Pharmacol. 2005 Oct;56(4):415-20. doi: 10.1007/s00280-005-1016-1. Epub 2005 Apr 19. Cancer Chemother Pharmacol. 2005. PMID: 15838655 Clinical Trial.
An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients.
Bedognetti D, Rubagotti A, Conti G, Francesca F, De Cobelli O, Canclini L, Gallucci M, Aragona F, Di Tonno P, Cortellini P, Martorana G, Lapini A, Boccardo F. Bedognetti D, et al. Among authors: conti g. Eur Urol. 2010 Feb;57(2):238-45. doi: 10.1016/j.eururo.2009.05.019. Epub 2009 May 19. Eur Urol. 2010. PMID: 19481335 Clinical Trial.
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study.
Gacci M, Artibani W, Bassi P, Bertoni F, Bracarda S, Briganti A, Carmignani G, Carmignani L, Conti G, Corvò R, De Nunzio C, Fusco F, Graziotti P, Greco I, Maggi S, Magrini SM, Mirone V, Montironi R, Morgia G, Muto G, Noale M, Pecoraro S, Porreca A, Ricardi U, Russi E, Russo G, Salonia A, Simonato A, Serni S, Tomasini D, Tubaro A, Zagonel V, Crepaldi G; MIRROR-SIU/LUNA Study Group and the Pros-IT CNR Study Group. Gacci M, et al. Among authors: conti g. World J Urol. 2021 May;39(5):1445-1452. doi: 10.1007/s00345-020-03350-5. Epub 2020 Aug 1. World J Urol. 2021. PMID: 32740803
Adaptation and validation of an Italian version of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI).
Bellardita L, Damiano R, Porpiglia F, Scattoni V, Amodeo A, Bortolus R, Lapini A, Cocci A, Cicalese V, Caponera M, Mastrangelo P, Francesca F, Valdagni R, Taverna G, di Trapani D, Leonardi R, Minocci D, Gaboardi F, Montanari E, Conti G. Bellardita L, et al. Among authors: conti g. Eur Rev Med Pharmacol Sci. 2016 Jul;20(13):2773-8. Eur Rev Med Pharmacol Sci. 2016. PMID: 27424974 Free article.
Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panel.
Baldari S, Boni G, Bortolus R, Caffo O, Conti G, De Vincentis G, Monari F, Procopio G, Santini D, Seregni E, Valdagni R. Baldari S, et al. Among authors: conti g. Crit Rev Oncol Hematol. 2017 May;113:43-51. doi: 10.1016/j.critrevonc.2017.03.001. Epub 2017 Mar 6. Crit Rev Oncol Hematol. 2017. PMID: 28427521 Review.
1,447 results